Literature DB >> 10898420

Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia.

P A Kaufmann1, T Gnecchi-Ruscone, K P Schäfers, T F Lüscher, P G Camici.   

Abstract

OBJECTIVES: The present study evaluates the impact of total cholesterol (TC) and its subfractions on coronary flow reserve (CFR), an index of the integrated function of the coronary circulation, in asymptomatic subjects.
BACKGROUND: Endothelial dysfunction of the coronary microcirculation has been reported in asymptomatic subjects with hypercholesterolemia.
METHODS: Using oxygen-15-labeled water and positron emission tomography, myocardial blood flow (MBF, in ml/min per g) was measured at rest and during intravenous adenosine (140 microg/kg body weight per min) in 80 asymptomatic nonsmoking men: group 1 (n = 61; age 45 +/- 7 years) had normal TC (< or =6.5 mmol/liter or < or =250 mg/dl) and group 2 (n = 19; age 48 +/- 10 years) had elevated TC.
RESULTS: Total cholesterol were 5.1 +/- 0.8 and 7.2 +/- 0.7 mmol/liter in groups 1 and 2 (p < 0.0005), respectively; low density lipoprotein (LDL) cholesterol levels were 3.2 +/- 0.8 and 4.9 +/- 0.7 mmol/liter (p < 0.0005); high density lipoprotein (HDL) cholesterol levels were 1.1 +/- 0.3 and 1.0 +/- 0.4 mmol/liter (p = NS); and triglyceride levels were 1.8 +/- 1.3 and 3.0 +/- 1.8 mmol/liter (p < 0.005). Groups 1 and 2 did not differ with regard to MBF at rest (0.87 +/- 0.14 vs. 0.84 +/- 0.14), MBF during adenosine (3.63 +/- 1.02 vs. 3.30 +/- 0.86) or CFR (4.23 +/-1.29 vs. 3.95 +/- 0.93). A significant but weak correlation was found between CFR and HDL in group 1 (r = 0.29, p < 0.05), but not in group 2. In contrast, a significant inverse correlation between LDL and CFR was found in group 2 (r = -0.61, p < 0.05), but not in group 1.
CONCLUSIONS: Low density lipoprotein cholesterol but not TC correlated inversely with CFR in hypercholesterolemic subjects. Thus, LDL-induced coronary microvascular dysfunction could play an important role in the pathogenesis of coronary artery disease and its complications.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898420     DOI: 10.1016/s0735-1097(00)00697-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  46 in total

Review 1.  Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Authors:  Martin Hersberger; Arnold von Eckardstein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  Diagnostic and prognostic value of non-invasive imaging in known or suspected coronary artery disease.

Authors:  J D Schuijf; D Poldermans; L J Shaw; J W Jukema; H J Lamb; A de Roos; W Wijns; E E van der Wall; J J Bax
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-01       Impact factor: 9.236

Review 3.  Role of PET in the evaluation and understanding of coronary physiology.

Authors:  Thomas H Schindler; Xiao-Li Zhang; Gabriella Vincenti; Leila Mhiri; René Lerch; Heinrich R Schelbert
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

Review 4.  Coronary vasomotor function assessed by positron emission tomography.

Authors:  Nagara Tamaki; Keiichiro Yoshinaga; Masanao Naya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-24       Impact factor: 9.236

5.  Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography.

Authors:  Masanao Naya; Venkatesh L Murthy; Viviany R Taqueti; Courtney R Foster; Josh Klein; Mariya Garber; Sharmila Dorbala; Jon Hainer; Ron Blankstein; Frederick Resnic; Marcelo F Di Carli
Journal:  J Nucl Med       Date:  2014-01-09       Impact factor: 10.057

6.  Abnormal glucose and lipid control in non-ischemic left ventricular dysfunction.

Authors:  Danilo Neglia; Tiziana Sampietro; Cecilia Vecoli; Riccardo Liga; Giuseppe Rossi; Elena Filidei; Federico Bigazzi; Patricia Iozzo; Daniela Giannessi; Antonio L'Abbate; Daniele Rovai
Journal:  J Nucl Cardiol       Date:  2012-08-10       Impact factor: 5.952

7.  Protocol for measuring myocardial blood flow by PET/CT in cats.

Authors:  Simone D Jenni; Tiziano Schepis; Rolf Jenni; Patrick T Siegrist; Philipp A Kaufmann; Tony M Glaus
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09-26       Impact factor: 9.236

Review 8.  CFR and FFR assessment with PET and CTA: strengths and limitations.

Authors:  Ryo Nakazato; Ran Heo; Jonathon Leipsic; James K Min
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

9.  Reversible impairment of coronary flow reserve in takotsubo cardiomyopathy: a myocardial PET study.

Authors:  Mauro Feola; Stephane Chauvie; Gian Luca Rosso; Alberto Biggi; Flavio Ribichini; Marco Bobbio
Journal:  J Nucl Cardiol       Date:  2008-07-31       Impact factor: 5.952

Review 10.  Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress.

Authors:  Munir Boodhwani; Frank W Sellke
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.